www.ericratino...
We are currently evaluating cases involving the HIV drug known as TDF (Tenofovir DF), or “Truvada,” on behalf of patients who suffered bone density loss, kidney damage, and lactic acidosis. Gilead, TDF’s manufacturer, failed to warn HIV patients about the drug’s serious side effects, and allegedly withholding the release of a safer drug for as long as ten years in order to maximize their profits.
TDF falls in a class of HIV drugs that block the action of an HIV enzyme, which helps to keep the virus from multiplying. It is used in combination with other medications to help contain the HIV virus and extend the lives of HIV patients. Because it is not readily absorbed into the body, however, higher doses are required to maintain its effectiveness. These high doses have been shown to create severe side effects, damaging the users’ kidneys and decreasing bone density.
If you or someone you know have experienced any of the above side effects after undergoing treatment with a TDF medication, you don’t have to face this battle alone. Call us today for a free and confidential case evaluation at (866) 527-4278.
6 окт 2024
